Reducing the osteoporosis treatment gap: an interview with UCB's Pascale Richetta

Dr. Pascale Richetta is Executive Vice President and Head of the Bone Patient Value Unit at UCB (Brussels, Belgium). She joined UCB in 2016 following over 20 years’ experience in the pharma and biotech industry. After completing her MD at the University of Poitiers (France), she spent time as vice p...

Descripción completa

Detalles Bibliográficos
Autor principal: Richetta, Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2017
Materias:
Interview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778375/
https://www.ncbi.nlm.nih.gov/pubmed/29379635
http://dx.doi.org/10.4155/fsoa-2017-0110
Descripción
Sumario:Dr. Pascale Richetta is Executive Vice President and Head of the Bone Patient Value Unit at UCB (Brussels, Belgium). She joined UCB in 2016 following over 20 years’ experience in the pharma and biotech industry. After completing her MD at the University of Poitiers (France), she spent time as vice president at Abbvie/Abbott and has also held positions at GlaxoSmithKline, Ipsen and Servier. Through the course of her career she acquired impressive commercial experience managing both traditional pharmaceuticals and complex biologics and her knowledge of markets around the world is key to helping UCB prepare for future product launches.

Ejemplares similares